Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

Stephen J. Greene,Sujung Choi,Steven J. Lippmann,Robert J. Mentz,Melissa A. Greiner,N. Chantelle Hardy,Bradley G. Hammill,Nancy Luo,Marc D. Samsky,Paul A. Heidenreich,Warren K. Laskey,Clyde W. Yancy,Pamela N. Peterson,Lesley H. Curtis,Adrian F. Hernandez,Gregg C. Fonarow,Emily C. OBrien

Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

2021

Stephen J. Greene
Sujung Choi
Steven J. Lippmann
Robert J. Mentz
Melissa A. Greiner
N. Chantelle Hardy
Bradley G. Hammill
Nancy Luo
Marc D. Samsky
Paul A. Heidenreich
Warren K. Laskey
Clyde W. Yancy
Pamela N. Peterson
Lesley H. Curtis
Adrian F. Hernandez
Gregg C. Fonarow
Emily C. OBrien

Background Sacubitril/Valsartan has been highly efficacious in randomized trials of heart failure with reduced ejection fraction (HFrEF). However, the effectiveness of sacubitril/valsartan in older...

Keywords:

Sacubitril
clinical effectiveness
Valsartan
Ejection fraction
Medicine
Heart failure
Cardiology
Internal medicine
Randomized controlled trial
Sacubitril, Valsartan

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations